• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中的代谢异质性——免疫治疗的新标志物。

Metabolic heterogeneity in tumor microenvironment - A novel landmark for immunotherapy.

机构信息

The First Affiliated Hospital of Ningbo University, Ningbo 315211, Zhejiang, China.

Harbin Medical University Cancer Hospital, Harbin 150081, Heilongjiang, China.

出版信息

Autoimmun Rev. 2024 Jun;23(6):103579. doi: 10.1016/j.autrev.2024.103579. Epub 2024 Jul 14.

DOI:10.1016/j.autrev.2024.103579
PMID:39004158
Abstract

The surrounding non-cancer cells and tumor cells that make up the tumor microenvironment (TME) have various metabolic rhythms. TME metabolic heterogeneity is influenced by the intricate network of metabolic control within and between cells. DNA, protein, transport, and microbial levels are important regulators of TME metabolic homeostasis. The effectiveness of immunotherapy is also closely correlated with alterations in TME metabolism. The response of a tumor patient to immunotherapy is influenced by a variety of variables, including intracellular metabolic reprogramming, metabolic interaction between cells, ecological changes within and between tumors, and general dietary preferences. Although immunotherapy and targeted therapy have made great strides, their use in the accurate identification and treatment of tumors still has several limitations. The function of TME metabolic heterogeneity in tumor immunotherapy is summarized in this article. It focuses on how metabolic heterogeneity develops and is regulated as a tumor progresses, the precise molecular mechanisms and potential clinical significance of imbalances in intracellular metabolic homeostasis and intercellular metabolic coupling and interaction, as well as the benefits and drawbacks of targeted metabolism used in conjunction with immunotherapy. This offers insightful knowledge and important implications for individualized tumor patient diagnosis and treatment plans in the future.

摘要

肿瘤微环境(TME)中的周围非癌细胞和肿瘤细胞具有各种代谢节律。TME 代谢异质性受细胞内和细胞间代谢控制复杂网络的影响。DNA、蛋白质、运输和微生物水平是 TME 代谢平衡的重要调节剂。免疫疗法的有效性也与 TME 代谢的改变密切相关。肿瘤患者对免疫疗法的反应受到多种变量的影响,包括细胞内代谢重编程、细胞间代谢相互作用、肿瘤内和肿瘤间的生态变化以及一般的饮食偏好。尽管免疫疗法和靶向疗法已经取得了很大的进展,但它们在肿瘤的准确识别和治疗中的应用仍存在一些局限性。本文总结了 TME 代谢异质性在肿瘤免疫治疗中的作用。它重点讨论了肿瘤进展过程中代谢异质性的发展和调节,细胞内代谢平衡和细胞间代谢偶联和相互作用失衡的精确分子机制和潜在临床意义,以及与免疫疗法联合使用的靶向代谢的优缺点。这为未来个体化肿瘤患者诊断和治疗计划提供了有见地的知识和重要启示。

相似文献

1
Metabolic heterogeneity in tumor microenvironment - A novel landmark for immunotherapy.肿瘤微环境中的代谢异质性——免疫治疗的新标志物。
Autoimmun Rev. 2024 Jun;23(6):103579. doi: 10.1016/j.autrev.2024.103579. Epub 2024 Jul 14.
2
Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy.肿瘤微环境的代谢重编程以增强免疫疗法。
BMB Rep. 2024 Sep;57(9):388-399. doi: 10.5483/BMBRep.2024-0031.
3
Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.靶向肿瘤相关巨噬细胞的脂质代谢重编程:癌症免疫治疗的新视角。
Cell Oncol (Dordr). 2024 Apr;47(2):415-428. doi: 10.1007/s13402-023-00881-y. Epub 2023 Sep 30.
4
Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy.肿瘤免疫治疗中的靶向甲羟戊酸途径与自噬
Curr Cancer Drug Targets. 2024;24(9):890-909. doi: 10.2174/0115680096273730231206054104.
5
Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective.通过纳米医学重编程免疫抑制性肿瘤微环境:免疫代谢观点。
EBioMedicine. 2024 Sep;107:105301. doi: 10.1016/j.ebiom.2024.105301. Epub 2024 Aug 22.
6
Targeting metabolism to enhance immunotherapy within tumor microenvironment.靶向代谢以增强肿瘤微环境中的免疫治疗。
Acta Pharmacol Sin. 2024 Oct;45(10):2011-2022. doi: 10.1038/s41401-024-01304-w. Epub 2024 May 29.
7
A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022.2003 年至 2022 年肿瘤微环境代谢重编程的文献计量分析。
Cancer Rep (Hoboken). 2024 Aug;7(8):e2146. doi: 10.1002/cnr2.2146.
8
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.胃癌肿瘤微环境代谢重编程在免疫治疗中的作用及机制。
Cell Death Dis. 2022 Apr 20;13(4):378. doi: 10.1038/s41419-022-04821-w.
9
The MCIB Model: A Novel Theory for Describing the Spatial Heterogeneity of the Tumor Microenvironment.MCIB 模型:一种描述肿瘤微环境空间异质性的新理论。
Int J Mol Sci. 2024 Sep 29;25(19):10486. doi: 10.3390/ijms251910486.
10
Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.代谢重编程在肿瘤免疫逃逸和免疫治疗中的新作用。
Sci China Life Sci. 2021 Apr;64(4):534-547. doi: 10.1007/s11427-019-1735-4. Epub 2020 Aug 17.

引用本文的文献

1
Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity.双精氨酸酶抑制剂OATD-02对肿瘤微环境的代谢重编程增强抗癌免疫力。
Sci Rep. 2025 May 28;15(1):18741. doi: 10.1038/s41598-025-03446-1.
2
Integrating multi-omics and machine learning methods reveals the metabolism of amino acids and derivatives-related signature in colorectal cancer.整合多组学和机器学习方法揭示了结直肠癌中氨基酸及其衍生物相关特征的代谢情况。
Front Oncol. 2025 Mar 26;15:1565090. doi: 10.3389/fonc.2025.1565090. eCollection 2025.
3
Disulfidptosis: a novel gene-based signature predicts prognosis and immunotherapy efficacy of pancreatic adenocarcinoma.
二硫化物诱导的细胞焦亡:一种基于新基因的特征可预测胰腺腺癌的预后和免疫治疗疗效。
Discov Oncol. 2025 Mar 12;16(1):308. doi: 10.1007/s12672-025-02053-w.
4
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance.代谢交叉点:解析胃肠道癌耐药中免疫细胞的动态变化
Cancer Drug Resist. 2025 Feb 8;8:7. doi: 10.20517/cdr.2024.164. eCollection 2025.